See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Puma Biotechnology, Inc. (PBYI) - free report >>
Loma Negra Compania Industrial Argentina S.A. Sponsored ADR (LOMA) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Puma Biotechnology, Inc. (PBYI) - free report >>
Loma Negra Compania Industrial Argentina S.A. Sponsored ADR (LOMA) - free report >>
Image: Bigstock
New Strong Buy Stocks for May 13th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Atlantic Power Corporation : This independent electric power producer has seen the Zacks Consensus Estimate for its current year earnings increasing 87.5% over the last 30 days.
Atlantic Power Corporation Price and Consensus
Atlantic Power Corporation price-consensus-chart | Atlantic Power Corporation Quote
Loma Negra Compania Industrial Argentina SA (LOMA - Free Report) : This cement manufacturer has seen the Zacks Consensus Estimate for its current year earnings increasing 2.3% over the last 60 days.
Loma Negra Compania Industrial Argentina SA Sponsored ADR Price and Consensus
Loma Negra Compania Industrial Argentina SA Sponsored ADR price-consensus-chart | Loma Negra Compania Industrial Argentina SA Sponsored ADR Quote
Puma Biotechnology Inc (PBYI - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 27.7% over the last 60 days.
Puma Biotechnology Inc Price and Consensus
Puma Biotechnology Inc price-consensus-chart | Puma Biotechnology Inc Quote
Karuna Therapeutics Inc : This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 22% over the last 60 days.
Karuna Therapeutics Inc Price and Consensus
Karuna Therapeutics Inc price-consensus-chart | Karuna Therapeutics Inc Quote
Livongo Health Inc : This consumer digital health company has seen the Zacks Consensus Estimate for its current year earnings increasing 22.2% over the last 60 days.
Livongo Health Inc Price and Consensus
Livongo Health Inc price-consensus-chart | Livongo Health Inc Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>